Tag: Antibody-Drug-Conjugate
IDT Australia receives grant to establish first commercial ADC manufacturing hub
IDT Australia Limited announced its successful bid for a Victoria State Government grant worth $3.8 million to support the creation of Australia’s inaugural cGMP Antibody-Drug-Conjugate (ADC) manufacturing facility.
Featured Article
Responding to manufacturing demand and performance signals
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.
